Strides' anti-bacterial injection receives FDA approval

10/3/2011 | Economic Times (India), The

The FDA authorized Strides Arcolab's Clindamycin Injection USP to treat bacterial infection. This marks the 12th drug approval under Strides' marketing collaboration with Sagent Pharmaceuticals. The drug will be launched early next year in single-use and bulk-pack vials, Strides said.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA